SKN | Tarsier Pharma Ltd. IPO: Biotech Debut Tests Investor Appetite for Early-Stage Drug Development
Tarsier Pharma Ltd. is preparing for a closely watched IPO that comes amid renewed but selective investor interest in clinical-stage biotechnology listings.
The company is...
SKN | CALM Chain International Expands IPO by 67% Ahead of $30 Million Nasdaq Debut
CALM Chain International, a Hong Kong-based provider of human resources services, has significantly increased the size of its planned U.S. initial public offering, signaling...
SKN | SK hynix Files for Potential $29.4 Billion U.S. IPO as AI-Driven Memory Demand Accelerates
South Korean semiconductor giant SK hynix has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering that could reportedly...
SKN | uniQure (QURE) Surges Nearly 76% in Five Days as Gene Therapy Pipeline Reignites Investor Optimism
Shares of uniQure N.V. (NASDAQ: QURE) have staged a remarkable rally, climbing nearly 76% over the past five trading days and closing at $49.04....
SKN | Viking Therapeutics, Inc. Draws Investor Attention as Biotech Appetite Returns to Growth-Stage Drug Developers
Viking Therapeutics, Inc. is moving back into focus among biotech investors as capital markets reopen selectively for clinical-stage pharmaceutical companies. The company’s anticipated capital...